GDPD3 and chronic myelogenous leukemia, BCR-ABL1 positive: Another study has indicated that increased expression of the enzyme Gdpd3 (lysophospholipase D), which activates lysophospholipid metabolism, can eventually lead to stem cell quiescence and TKI resistance in CML.